Ovarian cancer can be difficult to diagnose quickly as symptoms can resemble less serious conditions. Currently there is no reliable screening test. Survival rates are low overall around the world. Incidence and mortality are on the rise everywhere, but with disproportionately higher rates in low- and middle-income countries. About 20–25% of those diagnosed with ovarian cancer have a hereditary tendency to develop the disease and around 10–20% of ovarian cancer overall are linked to an inherited genetic mutation in one of two genes – BRCA1 and BRCA2 – although variants in other genes can also increase the risk of ovarian cancer.
New research commissioned by the World Ovarian Cancer Coalition shows the huge socioeconomic burden of ovarian cancer affecting not only patients living with the disease but also their families, caregivers, health systems and economies. The groundbreaking Every Woman Study™ highlights the low awareness among women of the disease and lack of knowledge about their potential genetic risk. In addition, obtaining an accurate diagnosis was identified as a major barrier to better outcomes. Without urgent action we will lose 8 million women to ovarian cancer by 2050.
Now is the time to address this global challenge by using this evidence and taking action.
The World Ovarian Cancer Coalition has established the Global Expert Advisory Group on Ovarian Cancer bringing together patient advocates, leading clinicians and policy makers from around the world to move this initiative forward. The Group has identified three key areas of focus:
Building community and policymaker awareness;
Optimizing routes to diagnosis and;
Driving access to services and treatment for hereditary ovarian cancer
The Group will develop a framework outlining global initiatives which will have an impact at country level, reinforcing the Coalition’s mission to ensure that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life possible, no matter where they live.
The Co-Chairs
Co-founder & Past Chair, World Ovarian Cancer Coalition, Former CEO, Target Ovarian Cancer (UK)
Annwen Jones OBE
Gynaecological Oncologist, Groote Schuur Hospital/University of Cape Town (South Africa)
Ass. Prof. Tracey Adams
Co-founder & Past Chair, World Ovarian Cancer Coalition, Former CEO, Target Ovarian Cancer (UK)
Annwen Jones OBE
SHARE
Annwen is the former CEO of Target Ovarian Cancer, the UK’s leading ovarian cancer charity, which she helped establish in 2008. Annwen is also the Past Chair of the Board of Directors of The Coalition. She was a co-founder of the Coalition, the first of its kind, in 2016 and co-chaired the Expert Advisory Panel for the seminal Every Woman Study™ published in 2018. Annwen has over 25 years’ experience of leadership, strategy, and management in the non-profit sector. Her several leadership roles include CEO of Ovarian Cancer Action; and she is on the Board of AMRC, the leading voice of UK medical research charities.
SHARE
Gynaecological Oncologist, Groote Schuur Hospital/University of Cape Town (South Africa)
Ass. Prof. Tracey Adams
SHARE
Tracey is a subspecialist Gynaecological Oncologist in the Department of Obstetrics and Gynaecology, Groote Schuur Hospital/University of Cape Town. Her research interests include ovarian cancer, peri-operative care and multizonal HPV disease especially in a LMIC setting. She is secretary of the South African Society of Gynaecological Oncology (SASGO) and her affiliations include UCT Global Surgery and the SA MRC UCT GCRC (Gynaecological Cancer Research Centre).
SHARE
Members
Assistant at Gynecologic Oncology Department Barretos Cancer Hospítal (Brazil)
Dr. Carlos Andrade
Lecturer, Wolfson Institute of Population Health (UK)
Dr. Garth Funston
Patient Advocate (India & Luxembourg)
Nimkee Gupta
Retired assistant deputy minister in the Government of Canada, Patient advocate (Canada)
Jennifer Hollington
First Vice-Rector, Asfendiyarov Kazakh National Medical University (Kazakhstan)
Professor of Gynaecological Oncology, Wolfson Institute of Population Health (UK)
Prof. Ranjit Manchanda
Prof. Ursula Matulonis, Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute (US)
Prof. Ursula Matulonis
Founder and Director, KolGOTrg, Gynaecological Oncologist/Surgeon, James Cook University Hospital and Newcastle University (India & UK)
Dr. Asima Mukhopadhyay
Consultant Obstetrician Gynaecologist, Ahmadu Bello University (Nigeria)
Dr. Aisha Mustapha
Head of Unit, Sanatario Allende Cerro (Argentina)
Asst. Prof. Florencia Noll
Head, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)
Prof. Amit Oza
CEO, Inherited Cancers Australia (Australia)
Sarah Powell
Oncology Center, Mansoura University (Egypt)
Prof. Basel Refky
Professor, Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA (US)
Dr. Ritu Salani
Patient advocate (UK)
Sbba Siddique
Gynaecological oncology, University of Birmingham (UK)
Prof. Sudha Sundar
Founder & Executive Director, Global Focus on Cancer (US)
Carolyn Taylor
Director Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy, Kings College of London, and Board Member, World Ovarian Cancer Coalition (Switzerland and UK)
Dr. Julie Torode
Assistant at Gynecologic Oncology Department Barretos Cancer Hospítal (Brazil)
Dr. Carlos Andrade
SHARE
SHARE
Lecturer, Wolfson Institute of Population Health (UK)
Dr. Garth Funston
SHARE
SHARE
Patient Advocate (India & Luxembourg)
Nimkee Gupta
SHARE
SHARE
Retired assistant deputy minister in the Government of Canada, Patient advocate (Canada)
Jennifer Hollington
SHARE
SHARE
First Vice-Rector, Asfendiyarov Kazakh National Medical University (Kazakhstan)
Professor of Gynaecological Oncology, Wolfson Institute of Population Health (UK)
Prof. Ranjit Manchanda
SHARE
SHARE
Prof. Ursula Matulonis, Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute (US)
Prof. Ursula Matulonis
SHARE
SHARE
Founder and Director, KolGOTrg, Gynaecological Oncologist/Surgeon, James Cook University Hospital and Newcastle University (India & UK)
Dr. Asima Mukhopadhyay
SHARE
SHARE
Consultant Obstetrician Gynaecologist, Ahmadu Bello University (Nigeria)
Dr. Aisha Mustapha
SHARE
SHARE
Head of Unit, Sanatario Allende Cerro (Argentina)
Asst. Prof. Florencia Noll
SHARE
SHARE
Head, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)
Prof. Amit Oza
SHARE
SHARE
CEO, Inherited Cancers Australia (Australia)
Sarah Powell
SHARE
SHARE
Oncology Center, Mansoura University (Egypt)
Prof. Basel Refky
SHARE
SHARE
Professor, Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA (US)
Dr. Ritu Salani
SHARE
SHARE
Patient advocate (UK)
Sbba Siddique
SHARE
SHARE
Gynaecological oncology, University of Birmingham (UK)
Prof. Sudha Sundar
SHARE
SHARE
Founder & Executive Director, Global Focus on Cancer (US)
Carolyn Taylor
SHARE
SHARE
Director Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy, Kings College of London, and Board Member, World Ovarian Cancer Coalition (Switzerland and UK)